# China NMPA Inspection - Beihai Black Pearl Marine Biotechnology Co., Ltd. - August 23, 2019

Source: https://www.globalkeysolutions.net/records/china_inspection/beihai-black-pearl-marine-biotechnology-co-ltd/25e21eb8-4879-4ad5-86cb-c9491b86a0b5/
Source feed: China

> China NMPA unannounced inspection for Beihai Black Pearl Marine Biotechnology Co., Ltd. published August 23, 2019. The Guangxi Zhuang Autonomous Region Drug Administration conducted unannounced inspections of licensed cosmetics manufacturers in the region during Ju

---

## Details

- Record Type: CHINA_INSPECTION
- Title: Announcement of the Results of Unannounced Inspections of Cosmetic Manufacturers in Guangxi Zhuang Autonomous Region (Issue 1, 2019)
- Company Name: Beihai Black Pearl Marine Biotechnology Co., Ltd.
- Publication Date: 2019-08-23
- Product Type: Cosmetics
- Summary: The Guangxi Zhuang Autonomous Region Drug Administration conducted unannounced inspections of licensed cosmetics manufacturers in the region during June 2019. This initiative, part of the 2019 regional Cosmetics Supervision Work Plan, aimed to enhance oversight. Inspections, primarily occurring between June 25th and 28th, involved ten companies and were guided by the "Key Points for Cosmetics Production License Inspection." The findings consistently revealed various compliance issues. Most manufacturers were cited for multiple "defect items," encompassing both serious and general deficiencies. For example, Beihai Black Pearl Marine Biotechnology Co., Ltd. had 11 defects, 3 of which were serious, while Beihai Haizhu Yun Cosmetics Co., Ltd. had 12 defects, including 3 serious ones. More significant findings included Guangxi Xiangzhou Sisi Qingyuan Biotechnology Co., Ltd., which received 29 defect items (9 serious), leading to an immediate production suspension for rectification. Similarly, Guangxi Ruijin Industrial Co., Ltd. faced 16 defects, with 7 serious, also resulting in production suspension. Guangxi Dekun Yao Pharmaceutical Co., Ltd., already suspended, was mandated to obtain an inspection certificate before resuming operations. The general required actions for non-compliant companies included thorough rectification and subsequent re-inspection to ensure adherence to regulatory standards.

Company: https://www.globalkeysolutions.net/companies/beihai-black-pearl-marine-biotechnology-co-ltd/17bd00c3-da6a-4dcd-bbf2-a250a69500c2/